Sangamo Therapeutics Inc (NASDAQ:SGMO)

16.30
Delayed Data
As of May 24
 +0.30 / +1.88%
Today’s Change
6.55
Today|||52-Week Range
27.50
-0.61%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-26.4M-40.7M-71.7M-54.6M
 
 
 
 
 
Depreciation549.0K988.0K997.0K1.5M
 
 
 
 
 
Total Other Cash Flow10.5M6.9M15.4M8.5M
 
 
 
 
 
Funds From Operations-15.3M-32.8M-55.3M-44.6M
 
 
 
 
 
Funds From/For Other Operating Expenses-9.7M910.0K10.6M-55.7M
 
 
 
 
 
Net Cash Flow - Operating Activities-5.7M-33.7M-65.9M11.2M
 
 
 
 
 
 
InvestingIncrease In Investments-227.8M-258.0M-218.6M-252.3M
 
 
 
 
 
Decrease In Investments127.8M337.9M237.5M178.7M
 
 
 
 
 
Capital Expenditures-621.0K-2.4M-732.0K-3.8M
 
 
 
 
 
Other Investing - Uses0.000.000.00-3.5M
 
 
Net Cash Flow Investing-100.7M77.5M18.1M-80.9M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.00----
Long Term Debt Reduction0.000.000.00----
Net Proceeds Stock Sale106.7M6.8M1.1M98.1M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing--14.5M0.000.00
 
 
Other Uses - Financing4.6M1.5M776.0K654.0K
 
 
 
 
 
Net Cash Flow - Financing102.2M19.7M337.0K97.5M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.00--------
 
Net Change In Cash-4.2M63.5M-47.4M27.8M